Copepod
Much missed Moderator
- Relationship to Diabetes
- Type 1
"In the News" doesn't seem quite appropriate for a story about Medicines and Healthcare Products Regulatory Agency (MHRA) taking 2 years to change advice to patients about potential side effects of statins. Ben Goldacre writes the at least weekly "Bad Science" column in the Guardian newspaper - some of the best science coverage in the British general media, in my opinion.
http://www.guardian.co.uk/commentisfree/2009/nov/21/statins-side-effects-ben-goldacre
I'd like to highlight a couple of paragraphs, as this story is about the speed of changing advice to give patients proper information so they can make their own informed decisions:
"Now, before we go any further, we should be clear on one thing. There are lots of people who want to tell you that statins do more harm than good, and many of these people have vitamin pills and magic diet books to sell.
Back in the real world, the evidence shows that statins are effective: they reduce your risk of having a heart attack, and your risk of death over a given time period, but they reduce these risks as a proportion of your pre-existing risk, so if you are at high risk of having a heart attack to start with, a statin is more worthwhile than if you're moderate risk. Although, of course, you still have to decide if you're the kind of person who feels enthusiastic about taking a preventive drug every day for years on end."
http://www.guardian.co.uk/commentisfree/2009/nov/21/statins-side-effects-ben-goldacre
I'd like to highlight a couple of paragraphs, as this story is about the speed of changing advice to give patients proper information so they can make their own informed decisions:
"Now, before we go any further, we should be clear on one thing. There are lots of people who want to tell you that statins do more harm than good, and many of these people have vitamin pills and magic diet books to sell.
Back in the real world, the evidence shows that statins are effective: they reduce your risk of having a heart attack, and your risk of death over a given time period, but they reduce these risks as a proportion of your pre-existing risk, so if you are at high risk of having a heart attack to start with, a statin is more worthwhile than if you're moderate risk. Although, of course, you still have to decide if you're the kind of person who feels enthusiastic about taking a preventive drug every day for years on end."
Last edited: